GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

Future Care Trading Compnay SJSC 9544.SR · SAR

Health Care · Tadawul · 🇸🇦 Saudi Arabia

Compare

1.24

+2.48%

Close of 9 Nov 2026, in SAR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SAR, from our data supplier.

FY2025

Revenue

SAR 76.1m

FY2018FY2025

Net income

SAR 15.8m

FY2018FY2025

Free cash flow

SAR 8.8m

FY2018FY2025

Shareholders' equity

SAR 97.0m

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
RevenueSAR 76.1mSAR 53.6mSAR 51.0mSAR 34.1mSAR 72.0mSAR 58.6mSAR 30.3mSAR 16.9m
Operating incomeSAR 18.2mSAR 12.1mSAR 15.6mSAR 5.8mSAR 38.3mSAR 26.8mSAR 3.8mSAR 3.6m
Net incomeSAR 15.8mSAR 9.9mSAR 13.7mSAR 5.1mSAR 36.7mSAR 26.0mSAR 3.6mSAR 887,406
Diluted earnings per share0.030.020.030.010.072.600.360.09

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assetsSAR 110.7mSAR 95.8mSAR 84.1mSAR 68.2mSAR 65.7mSAR 28.3mSAR 10.9mSAR 3.7m
Cash and short-term investments—SAR 56.0mSAR 51.5mSAR 34.8mSAR 31.2mSAR 36,649SAR 31,420—
Total liabilitiesSAR 13.7mSAR 12.1mSAR 10.5mSAR 9.7mSAR 12.0mSAR 10.9mSAR 6.3mSAR 2.7m
Debt—SAR 2.1mSAR 2.3mSAR 2.3mSAR 2.5mSAR 2.7m——
Shareholders' equitySAR 97.0mSAR 83.7mSAR 19.0mSAR 58.5mSAR 53.7mSAR 17.4mSAR 4.6mSAR 987,406
Shares outstanding525m500m500m500m500m10m10m10m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operationsSAR 12.5mSAR 1.5mSAR 19.4mSAR 11.2mSAR 32.5mSAR 13.3mSAR 4.4mSAR 36,060
Capital spending−SAR 3.7m−SAR 3.1m−SAR 1.5m−SAR 2.8m−SAR 3.1m−SAR 294,498−SAR 2.4m−SAR 51,906
Free cash flowSAR 8.8m−SAR 1.6mSAR 18.0mSAR 8.4mSAR 29.4mSAR 13.0mSAR 2.0m−SAR 15,846

Latest quarters

By quarter end

Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022
RevenueSAR 41.7mSAR 34.3mSAR 28.7mSAR 25.0mSAR 27.9mSAR 23.0mSAR 19.1mSAR 15.0m
Operating incomeSAR 9.5mSAR 8.7mSAR 7.0mSAR 5.1mSAR 9.9mSAR 5.5mSAR 939,620SAR 4.8m
Net incomeSAR 7.6mSAR 8.1mSAR 4.7mSAR 5.1mSAR 7.8mSAR 5.9mSAR 356,737SAR 4.8m
Diluted earnings per share0.010.020.010.010.020.010.000.01
Cash from operations—SAR 9.0m−SAR 3.0mSAR 4.0mSAR 9.0mSAR 12.0mSAR 3.0mSAR 7.0m
Capital spending—−SAR 1.0m————−SAR 2.0m—
Free cash flow—SAR 8.0m————SAR 1.0m—
Total assetsSAR 110.7mSAR 102.1mSAR 95.8mSAR 88.4mSAR 84.1mSAR 75.0mSAR 68.2mSAR 67.3m
Cash and short-term investments—SAR 20.3mSAR 56.0mSAR 59.7mSAR 51.5mSAR 41.9mSAR 34.8mSAR 39.0m
Debt—SAR 400,448SAR 1.3mSAR 1.3mSAR 1.1mSAR 717,663SAR 221,270SAR 360,830
Shareholders' equitySAR 97.0mSAR 90.6mSAR 83.7mSAR 78.8mSAR 19.0mSAR 65.2mSAR 58.5mSAR 58.5m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue30.6%5.4%—
Operating income46.7%-7.4%—
Net income45.4%-9.5%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin23.3%24.0%33.8%—
Net margin19.7%20.7%31.0%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings64.3——228.2
Price to sales13.396.4145.734.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 100-for-1 split · 12 Jun 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.